Facebook Pixel Code
Cancer clinic space
Garron Family Cancer Centre


Policy and Economics Research in Childhood Cancer (PERCC)
Goals of PERCC
Strategies to Achieve Goals
PERCC Sponsors
Dr. Gupta discusses PERCC (Video)

Policy and Economics Research in Childhood Cancer (PERCC)

Over 80% of children with cancer live in low- and middle-income countries (LMICs); their cure rates lag far behind those of children in high-income countries (HICs). National Childhood Cancer Strategies hold the potential to increase childhood cancer cure rates across large LMIC populations, but are in place in only a handful of LMIC. Barriers to adoption include a lack of health policy, health economics and implementation research relevant to LMIC paediatric oncology. Through a collaborative approach PERCC will support LMICs in an effort to overcome these barriers.


Goals of PERCC:

  • Conduct health policy and health economics research relevant to the care of children with cancer in LMICs
  • Use the results of such research to inform advocacy and policy efforts at various national and international levels

Strategies to Achieve Goals:

  • Forming associations with both national and international stakeholders
  • Leveraging partnerships with various LMIC childhood cancer centres
  • Obtaining competitive grant funding and support through philanthropic sources
  • Building capacity for health policy and health economics research through graduate and post-graduate level training of individuals from both HICs and LMICs

PERCC Sponsors:

Garron Family Cancer Centre

Centre for Global Child Health

Back To Top


November 2018:
Dr. Sumit Gupta presents as Co-Chair of a Lancet Oncology Symposium at the 2018 SIOP Symposium in Kyoto, Japan.

May 2018:

SickKids-Harvard Cancer Medicines Collaborative: PERCC hosted a meeting with childhood cancer and essential medicines experts from Harvard University to establish the SickKids-Harvard Cancer Medicines Collaborative, a joint endeavour to promote research aimed at improving access to essential cancer medicines for children in low- and middle-income countries.


Centre for Global Child Health (C-GCH) Catalyst Grant on Global Childhood Cancer Access: the PERCC team was awarded the C-GCH Catalyst Grant on Global Childhood Cancer Access for their project: Global childhood cancer drug access: A Ghanaian health system analysis”

The project (summary below) was presented at the C-GCH Weekly Seminar Series on May 2, 2018.

Project Summary:

A major impediment to the effective care of children with cancer in low and middle income countries (LMICs) is lack of access to essential medicines. To bridge existing knowledge gaps on childhood cancer drug access in LMICs, this project seeks to map and analyze the determinants of pediatric cancer drug access in Ghana, with specific attention to political, macroeconomic and health system context. It aims to equip local stakeholders with policy-relevant data to improve access to essential cancer medicines for children and adolescents with cancer in Ghana.

April 2018:

WHO Meeting on Cancer Drug Availability and Affordability: In response to the 2017 World Health Assembly (WHA) Resolution on Cancer, the WHO held an international advisory meeting to inform the development of a technical report on cancer drug availability and affordability. Dr. Avram Denburg attended as the PAHO-nominated regional representative for North America. The unique realities and needs of children with cancer were voiced, and recommendations related to paediatric drug pricing, production, procurement, and reimbursement will form part of the ultimate report.

January 2018:

Pediatric Oncology Roundtable to Transform Access to Global Essentials (PORTAGE): Together, Ruth Hoffman (CEO of the American Childhood Cancer Organization) and Avram Denburg launched the PORTAGE initiative, a joint endeavour of the International Society of Pediatric Oncology (SIOP), Childhood Cancer International (CCI) and Friends of Cancer Patients (FOCP). It kicked off at an international meeting in the UAE in January, with the patronage of HRH Queen of Sharjah. It brought together stakeholders from industry, global health governance institutions, civil society, and academia to identify tractable, scalable and sustainable solutions to current barriers to drug access, across domains of availability, accessibility, acceptability, affordability and quality. The meeting laid the groundwork for bilateral and multilateral partnerships to improve access to essential childhood cancer medicines. 

Back To Top